Микофенолат Мофетил Акорд

Mycophenolate Mofetil is an immunosuppressant medication used to prevent organ transplant rejection. This EU-sourced oral treatment helps manage immune responses effectively. A trusted option for transplant patients seeking reliable immunosuppression. Short-term and long-term use options available.

Mycophenolate Mofetil is primarily used to prevent organ transplant rejection in kidney, heart, and liver recipients. It works by suppressing the immune system to reduce the risk of the body attacking the new organ. This medication is often prescribed alongside other immunosuppressants for comprehensive post-transplant care. It may also be used in certain autoimmune conditions when directed by a healthcare professional.

Mycophenolate Mofetil helps maintain immune system balance after organ transplantation. Users may experience improved graft function and reduced risk of rejection episodes. Common effects include gastrointestinal changes and mild fatigue, which are typically monitored by healthcare providers. Regular follow-ups ensure the medication is working as intended.

Mycophenolate Mofetil should be handled with care, especially by pregnant individuals or those planning pregnancy, as it may cause birth defects. Blood tests are often required to monitor white blood cell counts and liver function during treatment. Avoid close contact with people who have infections, as the immune system may be weakened. Always follow healthcare provider instructions for safe use.

Mycophenolate Mofetil may interact with other immunosuppressants, antibiotics, or medications affecting the immune system. Combining it with certain vaccines or live vaccines is not recommended due to reduced effectiveness. Alcohol and herbal supplements may also alter its effects. Always inform your healthcare provider about all medications and supplements you are taking.